GE HealthCare Technologies Inc. (NASDAQ: GEHC) Stock Competitors & Peer Comparison
See GEHC's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GEHC and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GEHC | $69.72 | -1.19% | 31.5B | 15.29 | $4.56 | +0.20% |
| ABT | $108.79 | -1.52% | 188.2B | 20.88 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $93.10 | +1.00% | 119.2B | 16.84 | $5.53 | +3.08% |
| SYK | $307.99 | -1.35% | 118.1B | 23.00 | $13.39 | +1.13% |
| BSX | $46.95 | -2.94% | 69.8B | 15.15 | $3.10 | N/A |
| EW | $89.78 | -1.15% | 51.7B | 33.25 | $2.70 | N/A |
| DXCM | $89.71 | +0.02% | 33.9B | 35.18 | $2.55 | N/A |
| PHG | $26.05 | -1.21% | 25.5B | 14.88 | $1.75 | +3.80% |
| ZBH | $98.92 | -0.58% | 19.1B | 11.67 | $8.48 | +0.97% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
GEHC vs ABT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ABT has a market cap of 188.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ABT trades at $108.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ABT's P/E ratio is 20.88. In terms of profitability, GEHC's ROE is +0.15%, compared to ABT's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
GEHC vs BSX-PA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, GEHC's ROE is +0.15%, compared to BSX-PA's ROE of +0.15%. Regarding short-term risk, GEHC is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BSX-PA's competition here
Medtronic plc (NYSE: MDT)
GEHC vs MDT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, MDT has a market cap of 119.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while MDT trades at $93.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas MDT's P/E ratio is 16.84. In terms of profitability, GEHC's ROE is +0.15%, compared to MDT's ROE of +0.14%. Regarding short-term risk, GEHC is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
GEHC vs SYK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SYK has a market cap of 118.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SYK trades at $307.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SYK's P/E ratio is 23.00. In terms of profitability, GEHC's ROE is +0.15%, compared to SYK's ROE of +0.16%. Regarding short-term risk, GEHC is less volatile compared to SYK. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
GEHC vs BSX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BSX has a market cap of 69.8B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BSX trades at $46.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BSX's P/E ratio is 15.15. In terms of profitability, GEHC's ROE is +0.15%, compared to BSX's ROE of +0.15%. Regarding short-term risk, GEHC is less volatile compared to BSX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
GEHC vs EW Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, EW has a market cap of 51.7B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while EW trades at $89.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas EW's P/E ratio is 33.25. In terms of profitability, GEHC's ROE is +0.15%, compared to EW's ROE of +0.10%. Regarding short-term risk, GEHC is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check EW's competition here
DexCom, Inc. (NASDAQ: DXCM)
GEHC vs DXCM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, DXCM has a market cap of 33.9B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while DXCM trades at $89.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas DXCM's P/E ratio is 35.18. In terms of profitability, GEHC's ROE is +0.15%, compared to DXCM's ROE of +0.36%. Regarding short-term risk, GEHC is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check DXCM's competition here
Koninklijke Philips N.V. (NYSE: PHG)
GEHC vs PHG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PHG has a market cap of 25.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PHG trades at $26.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PHG's P/E ratio is 14.88. In terms of profitability, GEHC's ROE is +0.15%, compared to PHG's ROE of +0.10%. Regarding short-term risk, GEHC is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
GEHC vs ZBH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ZBH has a market cap of 19.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ZBH trades at $98.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ZBH's P/E ratio is 11.67. In terms of profitability, GEHC's ROE is +0.15%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, GEHC is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
GEHC vs ABMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ABMD's P/E ratio is 65.36. In terms of profitability, GEHC's ROE is +0.15%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, GEHC is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ABMD's competition here
Penumbra, Inc. (NYSE: PEN)
GEHC vs PEN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PEN trades at $321.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PEN's P/E ratio is 83.90. In terms of profitability, GEHC's ROE is +0.15%, compared to PEN's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
GEHC vs SWAV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SWAV's P/E ratio is 78.76. In terms of profitability, GEHC's ROE is +0.15%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, GEHC is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SWAV's competition here
Smith & Nephew plc (NYSE: SNN)
GEHC vs SNN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SNN has a market cap of 12.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SNN trades at $28.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SNN's P/E ratio is 13.50. In terms of profitability, GEHC's ROE is +0.15%, compared to SNN's ROE of +0.12%. Regarding short-term risk, GEHC is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SNN's competition here
Align Technology, Inc. (NASDAQ: ALGN)
GEHC vs ALGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ALGN has a market cap of 11.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ALGN trades at $159.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ALGN's P/E ratio is 14.57. In terms of profitability, GEHC's ROE is +0.15%, compared to ALGN's ROE of +0.10%. Regarding short-term risk, GEHC is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ALGN's competition here
Glaukos Corporation (NYSE: GKOS)
GEHC vs GKOS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, GKOS has a market cap of 10.6B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while GKOS trades at $180.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas GKOS's P/E ratio is -209.80. In terms of profitability, GEHC's ROE is +0.15%, compared to GKOS's ROE of -0.27%. Regarding short-term risk, GEHC is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check GKOS's competition here
Globus Medical, Inc. (NYSE: GMED)
GEHC vs GMED Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, GMED has a market cap of 10.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while GMED trades at $78.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas GMED's P/E ratio is 17.59. In terms of profitability, GEHC's ROE is +0.15%, compared to GMED's ROE of +0.12%. Regarding short-term risk, GEHC is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check GMED's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
GEHC vs BIO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BIO trades at $387.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BIO's P/E ratio is 41.79. In terms of profitability, GEHC's ROE is +0.15%, compared to BIO's ROE of +0.03%. Regarding short-term risk, GEHC is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BIO's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
GEHC vs BIO-B Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BIO-B has a market cap of 10.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BIO-B trades at $381.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BIO-B's P/E ratio is -67.15. In terms of profitability, GEHC's ROE is +0.15%, compared to BIO-B's ROE of +0.03%. Regarding short-term risk, GEHC is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BIO-B's competition here
Insulet Corp. (NASDAQ: PODD)
GEHC vs PODD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PODD has a market cap of 10.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PODD trades at $150.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PODD's P/E ratio is 25.65. In terms of profitability, GEHC's ROE is +0.15%, compared to PODD's ROE of +0.27%. Regarding short-term risk, GEHC is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PODD's competition here
Masimo Corporation (NASDAQ: MASI)
GEHC vs MASI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas MASI's P/E ratio is 44.43. In terms of profitability, GEHC's ROE is +0.15%, compared to MASI's ROE of +0.09%. Regarding short-term risk, GEHC is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
GEHC vs BRKR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BRKR has a market cap of 9B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BRKR trades at $59.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BRKR's P/E ratio is 29.85. In terms of profitability, GEHC's ROE is +0.15%, compared to BRKR's ROE of -0.03%. Regarding short-term risk, GEHC is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
GEHC vs BRKRP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BRKRP has a market cap of 8.8B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BRKRP trades at $438.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BRKRP's P/E ratio is 238.04. In terms of profitability, GEHC's ROE is +0.15%, compared to BRKRP's ROE of -0.03%. Regarding short-term risk, GEHC is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check BRKRP's competition here
Inari Medical, Inc. (NASDAQ: NARI)
GEHC vs NARI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NARI's P/E ratio is -59.24. In terms of profitability, GEHC's ROE is +0.15%, compared to NARI's ROE of -0.00%. Regarding short-term risk, GEHC is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NARI's competition here
Haemonetics Corporation (NYSE: HAE)
GEHC vs HAE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, HAE has a market cap of 4.7B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while HAE trades at $102.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas HAE's P/E ratio is 20.52. In terms of profitability, GEHC's ROE is +0.15%, compared to HAE's ROE of +0.11%. Regarding short-term risk, GEHC is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
GEHC vs LIVN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, LIVN has a market cap of 4.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while LIVN trades at $81.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas LIVN's P/E ratio is 19.29. In terms of profitability, GEHC's ROE is +0.15%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, GEHC is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check LIVN's competition here
Integer Holdings Corporation (NYSE: ITGR)
GEHC vs ITGR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ITGR trades at $125.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ITGR's P/E ratio is 19.76. In terms of profitability, GEHC's ROE is +0.15%, compared to ITGR's ROE of +0.07%. Regarding short-term risk, GEHC is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ITGR's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
GEHC vs IRTC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, IRTC has a market cap of 4.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while IRTC trades at $123.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas IRTC's P/E ratio is -287.05. In terms of profitability, GEHC's ROE is +0.15%, compared to IRTC's ROE of -0.09%. Regarding short-term risk, GEHC is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check IRTC's competition here
Axonics, Inc. (NASDAQ: AXNX)
GEHC vs AXNX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AXNX has a market cap of 3.6B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AXNX trades at $70.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AXNX's P/E ratio is -709.80. In terms of profitability, GEHC's ROE is +0.15%, compared to AXNX's ROE of -0.01%. Regarding short-term risk, GEHC is more volatile compared to AXNX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check AXNX's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
GEHC vs TMDX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, TMDX has a market cap of 3B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while TMDX trades at $86.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas TMDX's P/E ratio is 44.15. In terms of profitability, GEHC's ROE is +0.15%, compared to TMDX's ROE of +0.33%. Regarding short-term risk, GEHC is more volatile compared to TMDX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check TMDX's competition here
Neogen Corporation (NASDAQ: NEOG)
GEHC vs NEOG Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NEOG has a market cap of 2.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NEOG trades at $11.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NEOG's P/E ratio is 41.57. In terms of profitability, GEHC's ROE is +0.15%, compared to NEOG's ROE of -0.00%. Regarding short-term risk, GEHC is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NEOG's competition here
AxoGen, Inc. (NASDAQ: AXGN)
GEHC vs AXGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AXGN has a market cap of 2.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AXGN trades at $47.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AXGN's P/E ratio is 123.95. In terms of profitability, GEHC's ROE is +0.15%, compared to AXGN's ROE of -0.18%. Regarding short-term risk, GEHC is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AXGN's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
GEHC vs UFPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, UFPT has a market cap of 2.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while UFPT trades at $286.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas UFPT's P/E ratio is 29.27. In terms of profitability, GEHC's ROE is +0.15%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, GEHC is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check UFPT's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
GEHC vs ESTA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ESTA has a market cap of 2.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ESTA trades at $72.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ESTA's P/E ratio is -57.38. In terms of profitability, GEHC's ROE is +0.15%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, GEHC is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ESTA's competition here
NuVasive, Inc. (NASDAQ: NUVA)
GEHC vs NUVA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NUVA's P/E ratio is 75.00. In terms of profitability, GEHC's ROE is +0.15%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, GEHC is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NUVA's competition here
Novocure Ltd (NASDAQ: NVCR)
GEHC vs NVCR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NVCR has a market cap of 2.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NVCR trades at $17.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NVCR's P/E ratio is -13.57. In terms of profitability, GEHC's ROE is +0.15%, compared to NVCR's ROE of -0.44%. Regarding short-term risk, GEHC is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NVCR's competition here
Butterfly Network, Inc. (NYSE: BFLY)
GEHC vs BFLY Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BFLY has a market cap of 1.9B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BFLY trades at $7.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BFLY's P/E ratio is -30.35. In terms of profitability, GEHC's ROE is +0.15%, compared to BFLY's ROE of -0.38%. Regarding short-term risk, GEHC is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BFLY's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
GEHC vs INSP Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, INSP has a market cap of 1.8B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while INSP trades at $62.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas INSP's P/E ratio is 27.34. In terms of profitability, GEHC's ROE is +0.15%, compared to INSP's ROE of +0.18%. Regarding short-term risk, GEHC is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check INSP's competition here
CONMED Corporation (NYSE: CNMD)
GEHC vs CNMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CNMD trades at $49.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CNMD's P/E ratio is 10.84. In terms of profitability, GEHC's ROE is +0.15%, compared to CNMD's ROE of +0.06%. Regarding short-term risk, GEHC is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CNMD's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
GEHC vs ATEC Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ATEC has a market cap of 1.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ATEC trades at $9.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ATEC's P/E ratio is -155.50. In terms of profitability, GEHC's ROE is +0.15%, compared to ATEC's ROE of -8.19%. Regarding short-term risk, GEHC is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ATEC's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
GEHC vs TNDM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, TNDM has a market cap of 1.4B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while TNDM trades at $20.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas TNDM's P/E ratio is -21.97. In terms of profitability, GEHC's ROE is +0.15%, compared to TNDM's ROE of -0.46%. Regarding short-term risk, GEHC is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TNDM's competition here
Heska Corporation (NASDAQ: HSKA)
GEHC vs HSKA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas HSKA's P/E ratio is -62.49. In terms of profitability, GEHC's ROE is +0.15%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, GEHC is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check HSKA's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
GEHC vs IART Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, IART has a market cap of 1.3B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while IART trades at $16.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas IART's P/E ratio is 6.97. In terms of profitability, GEHC's ROE is +0.15%, compared to IART's ROE of -0.01%. Regarding short-term risk, GEHC is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check IART's competition here
Artivion, Inc. (NYSE: AORT)
GEHC vs AORT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AORT has a market cap of 1.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AORT trades at $25.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AORT's P/E ratio is 42.67. In terms of profitability, GEHC's ROE is +0.15%, compared to AORT's ROE of -0.01%. Regarding short-term risk, GEHC is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AORT's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
GEHC vs PRCT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PRCT trades at $21.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PRCT's P/E ratio is -11.02. In terms of profitability, GEHC's ROE is +0.15%, compared to PRCT's ROE of -0.31%. Regarding short-term risk, GEHC is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
GEHC vs AVNS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AVNS's P/E ratio is 27.77. In terms of profitability, GEHC's ROE is +0.15%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, GEHC is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check AVNS's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
GEHC vs LMRI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, LMRI has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while LMRI trades at $11.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas LMRI's P/E ratio is -23.15. In terms of profitability, GEHC's ROE is +0.15%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, GEHC is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check LMRI's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
GEHC vs SILK Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SILK's P/E ratio is -18.96. In terms of profitability, GEHC's ROE is +0.15%, compared to SILK's ROE of -0.35%. Regarding short-term risk, GEHC is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SILK's competition here
Enovis Corporation (NYSE: ENOV)
GEHC vs ENOV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ENOV has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ENOV trades at $19.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ENOV's P/E ratio is 5.55. In terms of profitability, GEHC's ROE is +0.15%, compared to ENOV's ROE of -0.68%. Regarding short-term risk, GEHC is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check ENOV's competition here
IRadimed Corporation (NASDAQ: IRMD)
GEHC vs IRMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while IRMD trades at $86.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas IRMD's P/E ratio is 43.51. In terms of profitability, GEHC's ROE is +0.15%, compared to IRMD's ROE of +0.23%. Regarding short-term risk, GEHC is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
GEHC vs FNA Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas FNA's P/E ratio is -19.83. In terms of profitability, GEHC's ROE is +0.15%, compared to FNA's ROE of -0.35%. Regarding short-term risk, GEHC is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check FNA's competition here
Bioventus Inc. (NASDAQ: BVS)
GEHC vs BVS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BVS has a market cap of 972.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BVS trades at $14.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BVS's P/E ratio is 18.89. In terms of profitability, GEHC's ROE is +0.15%, compared to BVS's ROE of +0.28%. Regarding short-term risk, GEHC is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BVS's competition here
CeriBell, Inc. (NASDAQ: CBLL)
GEHC vs CBLL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CBLL has a market cap of 932.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CBLL trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CBLL's P/E ratio is -13.96. In terms of profitability, GEHC's ROE is +0.15%, compared to CBLL's ROE of -0.45%. Regarding short-term risk, GEHC is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CBLL's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
GEHC vs BBNX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BBNX has a market cap of 896.2M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BBNX trades at $19.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BBNX's P/E ratio is -12.07. In terms of profitability, GEHC's ROE is +0.15%, compared to BBNX's ROE of -0.26%. Regarding short-term risk, GEHC is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BBNX's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
GEHC vs AHCO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AHCO has a market cap of 873.5M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AHCO trades at $6.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AHCO's P/E ratio is 13.10. In terms of profitability, GEHC's ROE is +0.15%, compared to AHCO's ROE of -0.15%. Regarding short-term risk, GEHC is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check AHCO's competition here
InMode Ltd. (NASDAQ: INMD)
GEHC vs INMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, INMD has a market cap of 853M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while INMD trades at $14.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas INMD's P/E ratio is 10.31. In terms of profitability, GEHC's ROE is +0.15%, compared to INMD's ROE of +0.12%. Regarding short-term risk, GEHC is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check INMD's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
GEHC vs AVR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, AVR has a market cap of 847.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while AVR trades at $8.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas AVR's P/E ratio is -4.49. In terms of profitability, GEHC's ROE is +0.15%, compared to AVR's ROE of -0.78%. Regarding short-term risk, GEHC is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check AVR's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
GEHC vs CSII Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CSII has a market cap of 844M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CSII's P/E ratio is -20.83. In terms of profitability, GEHC's ROE is +0.15%, compared to CSII's ROE of -0.14%. Regarding short-term risk, GEHC is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CSII's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
GEHC vs SIBN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SIBN has a market cap of 826.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SIBN trades at $18.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SIBN's P/E ratio is -54.82. In terms of profitability, GEHC's ROE is +0.15%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, GEHC is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SIBN's competition here
Varex Imaging Corporation (NASDAQ: VREX)
GEHC vs VREX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, VREX has a market cap of 779.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while VREX trades at $18.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas VREX's P/E ratio is 19.49. In terms of profitability, GEHC's ROE is +0.15%, compared to VREX's ROE of +0.05%. Regarding short-term risk, GEHC is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check VREX's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
GEHC vs SSII Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SSII has a market cap of 678.4M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SSII trades at $3.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SSII's P/E ratio is -66.12. In terms of profitability, GEHC's ROE is +0.15%, compared to SSII's ROE of -0.27%. Regarding short-term risk, GEHC is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SSII's competition here
Surmodics, Inc. (NASDAQ: SRDX)
GEHC vs SRDX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SRDX's P/E ratio is -34.66. In terms of profitability, GEHC's ROE is +0.15%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, GEHC is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SRDX's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
GEHC vs CTKB Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CTKB has a market cap of 607M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CTKB trades at $4.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CTKB's P/E ratio is -24.90. In terms of profitability, GEHC's ROE is +0.15%, compared to CTKB's ROE of -0.24%. Regarding short-term risk, GEHC is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CTKB's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
GEHC vs KIDS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, KIDS has a market cap of 580.2M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while KIDS trades at $22.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas KIDS's P/E ratio is -19.14. In terms of profitability, GEHC's ROE is +0.15%, compared to KIDS's ROE of -0.12%. Regarding short-term risk, GEHC is less volatile compared to KIDS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check KIDS's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
GEHC vs APEN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas APEN's P/E ratio is -9.43. In terms of profitability, GEHC's ROE is +0.15%, compared to APEN's ROE of -0.85%. Regarding short-term risk, GEHC is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check APEN's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
GEHC vs DCTH Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, DCTH has a market cap of 568.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while DCTH trades at $16.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas DCTH's P/E ratio is 1648.00. In terms of profitability, GEHC's ROE is +0.15%, compared to DCTH's ROE of +0.00%. Regarding short-term risk, GEHC is more volatile compared to DCTH. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check DCTH's competition here
ZimVie Inc. (NASDAQ: ZIMV)
GEHC vs ZIMV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, GEHC's ROE is +0.15%, compared to ZIMV's ROE of -0.01%. Regarding short-term risk, GEHC is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ZIMV's competition here
Cerus Corporation (NASDAQ: CERS)
GEHC vs CERS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CERS has a market cap of 517.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CERS trades at $2.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CERS's P/E ratio is -51.30. In terms of profitability, GEHC's ROE is +0.15%, compared to CERS's ROE of -0.10%. Regarding short-term risk, GEHC is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CERS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
GEHC vs NPCE Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NPCE has a market cap of 502.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NPCE trades at $14.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NPCE's P/E ratio is -25.88. In terms of profitability, GEHC's ROE is +0.15%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, GEHC is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check NPCE's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
GEHC vs TCMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, TCMD has a market cap of 496.5M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while TCMD trades at $22.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas TCMD's P/E ratio is 20.38. In terms of profitability, GEHC's ROE is +0.15%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, GEHC is less volatile compared to TCMD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TCMD's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
GEHC vs SGHT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SGHT has a market cap of 456M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SGHT trades at $8.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SGHT's P/E ratio is -14.96. In terms of profitability, GEHC's ROE is +0.15%, compared to SGHT's ROE of -0.51%. Regarding short-term risk, GEHC is more volatile compared to SGHT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SGHT's competition here
Carlsmed, Inc. (NASDAQ: CARL)
GEHC vs CARL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CARL has a market cap of 421.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CARL trades at $15.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CARL's P/E ratio is -10.85. In terms of profitability, GEHC's ROE is +0.15%, compared to CARL's ROE of -0.38%. Regarding short-term risk, GEHC is less volatile compared to CARL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CARL's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
GEHC vs CLPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CLPT has a market cap of 421.4M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CLPT trades at $14.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CLPT's P/E ratio is -11.91. In terms of profitability, GEHC's ROE is +0.15%, compared to CLPT's ROE of -1.88%. Regarding short-term risk, GEHC is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check CLPT's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
GEHC vs SENS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SENS has a market cap of 413.8M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SENS trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SENS's P/E ratio is -4.44. In terms of profitability, GEHC's ROE is +0.15%, compared to SENS's ROE of -1.66%. Regarding short-term risk, GEHC is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check SENS's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
GEHC vs PACB Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PACB has a market cap of 403.8M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PACB trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PACB's P/E ratio is -3.17. In terms of profitability, GEHC's ROE is +0.15%, compared to PACB's ROE of -49.62%. Regarding short-term risk, GEHC is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check PACB's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
GEHC vs OFIX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, OFIX has a market cap of 376.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while OFIX trades at $9.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas OFIX's P/E ratio is -6.06. In terms of profitability, GEHC's ROE is +0.15%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, GEHC is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check OFIX's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
GEHC vs CATX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CATX has a market cap of 354.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CATX trades at $3.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CATX's P/E ratio is -2.34. In terms of profitability, GEHC's ROE is +0.15%, compared to CATX's ROE of -0.42%. Regarding short-term risk, GEHC is more volatile compared to CATX. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CATX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
GEHC vs TMCI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, TMCI has a market cap of 316.6M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while TMCI trades at $4.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas TMCI's P/E ratio is -5.19. In terms of profitability, GEHC's ROE is +0.15%, compared to TMCI's ROE of -0.74%. Regarding short-term risk, GEHC is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TMCI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
GEHC vs SMLR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas SMLR's P/E ratio is 3.92. In terms of profitability, GEHC's ROE is +0.15%, compared to SMLR's ROE of +0.06%. Regarding short-term risk, GEHC is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check SMLR's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
GEHC vs TLSI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, TLSI has a market cap of 306.6M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while TLSI trades at $4.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas TLSI's P/E ratio is -2.96. In terms of profitability, GEHC's ROE is +0.15%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, GEHC is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check TLSI's competition here
CapsoVision, Inc. (NASDAQ: CV)
GEHC vs CV Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, CV has a market cap of 298.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while CV trades at $5.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas CV's P/E ratio is -2.39. In terms of profitability, GEHC's ROE is +0.15%, compared to CV's ROE of -1.78%. Regarding short-term risk, GEHC is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check CV's competition here
Avita Medical Inc. (NASDAQ: RCEL)
GEHC vs RCEL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, RCEL has a market cap of 271.8M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while RCEL trades at $10.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas RCEL's P/E ratio is -7.60. In terms of profitability, GEHC's ROE is +0.15%, compared to RCEL's ROE of +2.32%. Regarding short-term risk, GEHC is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check RCEL's competition here
RxSight, Inc. (NASDAQ: RXST)
GEHC vs RXST Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, RXST has a market cap of 270.7M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while RXST trades at $6.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas RXST's P/E ratio is -5.79. In terms of profitability, GEHC's ROE is +0.15%, compared to RXST's ROE of -0.17%. Regarding short-term risk, GEHC is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check RXST's competition here
Profound Medical Corp. (NASDAQ: PROF)
GEHC vs PROF Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, PROF has a market cap of 247.1M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while PROF trades at $6.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas PROF's P/E ratio is -6.94. In terms of profitability, GEHC's ROE is +0.15%, compared to PROF's ROE of -0.56%. Regarding short-term risk, GEHC is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check PROF's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
GEHC vs INFU Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, INFU has a market cap of 245.4M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while INFU trades at $12.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas INFU's P/E ratio is 29.66. In terms of profitability, GEHC's ROE is +0.15%, compared to INFU's ROE of +0.15%. Regarding short-term risk, GEHC is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check INFU's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
GEHC vs MGRM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas MGRM's P/E ratio is -12.00. In terms of profitability, GEHC's ROE is +0.15%, compared to MGRM's ROE of -0.85%. Regarding short-term risk, GEHC is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
GEHC vs ELMD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ELMD has a market cap of 228.4M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ELMD trades at $27.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ELMD's P/E ratio is 21.06. In terms of profitability, GEHC's ROE is +0.15%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, GEHC is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
GEHC vs NVRO Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas NVRO's P/E ratio is -1.91. In terms of profitability, GEHC's ROE is +0.15%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, GEHC is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check NVRO's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
GEHC vs BSGM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas BSGM's P/E ratio is -5.81. In terms of profitability, GEHC's ROE is +0.15%, compared to BSGM's ROE of +15.26%. Regarding short-term risk, GEHC is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check BSGM's competition here
Neuronetics, Inc. (NASDAQ: STIM)
GEHC vs STIM Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, STIM has a market cap of 189.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while STIM trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas STIM's P/E ratio is -6.18. In terms of profitability, GEHC's ROE is +0.15%, compared to STIM's ROE of -1.51%. Regarding short-term risk, GEHC is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check STIM's competition here
Lucid Diagnostics Inc. (NASDAQ: LUCD)
GEHC vs LUCD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, LUCD has a market cap of 181.5M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while LUCD trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas LUCD's P/E ratio is -2.57. In terms of profitability, GEHC's ROE is +0.15%, compared to LUCD's ROE of -4.04%. Regarding short-term risk, GEHC is less volatile compared to LUCD. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check LUCD's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
GEHC vs MDGS Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas MDGS's P/E ratio is -0.27. In terms of profitability, GEHC's ROE is +0.15%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, GEHC is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check MDGS's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
GEHC vs QIPT Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas QIPT's P/E ratio is -15.87. In terms of profitability, GEHC's ROE is +0.15%, compared to QIPT's ROE of -0.10%. Regarding short-term risk, GEHC is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check QIPT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
GEHC vs FOCL Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, FOCL has a market cap of 156.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while FOCL trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas FOCL's P/E ratio is -4.03. In terms of profitability, GEHC's ROE is +0.15%, compared to FOCL's ROE of -2.90%. Regarding short-term risk, GEHC is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check FOCL's competition here
Quantum-Si incorporated (NASDAQ: QSI)
GEHC vs QSI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, QSI has a market cap of 153.1M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while QSI trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas QSI's P/E ratio is -1.68. In terms of profitability, GEHC's ROE is +0.15%, compared to QSI's ROE of -0.47%. Regarding short-term risk, GEHC is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check QSI's competition here
Inogen, Inc. (NASDAQ: INGN)
GEHC vs INGN Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, INGN has a market cap of 147.6M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while INGN trades at $5.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas INGN's P/E ratio is -5.99. In terms of profitability, GEHC's ROE is +0.15%, compared to INGN's ROE of -0.13%. Regarding short-term risk, GEHC is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
GEHC vs QTRX Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, QTRX has a market cap of 121.5M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while QTRX trades at $2.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas QTRX's P/E ratio is -1.02. In terms of profitability, GEHC's ROE is +0.15%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, GEHC is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check QTRX's competition here
iCAD, Inc. (NASDAQ: ICAD)
GEHC vs ICAD Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas ICAD's P/E ratio is -20.37. In terms of profitability, GEHC's ROE is +0.15%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, GEHC is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check ICAD's competition here
LENSAR Inc (NASDAQ: LNSR)
GEHC vs LNSR Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, LNSR has a market cap of 101.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while LNSR trades at $8.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas LNSR's P/E ratio is 8.42. In terms of profitability, GEHC's ROE is +0.15%, compared to LNSR's ROE of +103.80%. Regarding short-term risk, GEHC is more volatile compared to LNSR. This indicates higher risk in terms of short-term price fluctuations for GEHC.Check LNSR's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
GEHC vs HJLI Comparison September 2026
GE HealthCare Technologies Inc. (NASDAQ: GEHC) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GEHC stands at 31.5B. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, GEHC is priced at $69.72 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GEHC currently has a P/E ratio of 15.29, whereas HJLI's P/E ratio is N/A. In terms of profitability, GEHC's ROE is +0.15%, compared to HJLI's ROE of -0.62%. Regarding short-term risk, GEHC is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for GEHC.Check HJLI's competition here